Funded projects

• 

  Dr Cynthia Sharpe

  Starship Children's Health, Health NZ Te Toka Tumai

  Project grant - $290,543 - Funding Round: 2025 B

  NEOLEV3 in Aotearoa New Zealand

  Seizures affect 1 in 300 babies in New Zealand and can be associated with lifelong developmental disabilities and epilepsy. The only approved treatment, Phenobarbital, has significant side effects and better treatments are urgently needed. This study will support New Zealand’s participation in an international trial of a potentially safer medication, Levetiracetam. It could lead to changes in neonatal seizure treatment in New Zealand, allowing babies with mild-to-moderate seizures to be spared the side effects associated with Phenobarbital treatment.